<DOC>
	<DOCNO>NCT01125020</DOCNO>
	<brief_summary>The study design investigate effect postoperative adjuvant chemotherapy prevention tumor recurrence metastasis hepatocellular carcinoma liver transplantation .</brief_summary>
	<brief_title>Impact Postoperative Adjuvant Chemotherapy Patients With Hepatocellular Carcinoma After Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>All liver transplantation patient hepatocellular carcinoma Dec 2008 May 2010 potentially eligible enrollment . Age le 18 year Treatment postoperative adjuvant chemotherapy Survival le 3 month liver transplantation Inability provide write informed consent prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>